In December 2018, Torrent Pharmaceuticals began a voluntary recall of losartan due to the presence of small traces of known carcinogens
Generic Drugs
In December 2018, January 2019, Torrent recalled 10 lots of losartan potassium 100 mg tablets
Teva Pharmaceuticals USA, Inc
Generics
Losartan
Tests found trace amounts of a potentially cancer-causing impurity In September 2019, Torrent Pharmaceuticals announced it was expanding its recall to an additional 3 lots of Losartan Potassium Tablets USP and 2 lots of Losartan Potassium/Hydrochlorothiazide December 11, 2018
It says the lots can contain amounts of N-Nitrosodiethylamine, or On December 20th 2018, Torrent Pharmaceuticals Limited announced a voluntary recall of 2 lots of Losartan potassium tablets, USP to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited
This expanded recall includes six (6) lots of bulk losartan potassium USP Tablets (two lots of 50 mg strength and four lots of 100 mg strength) due to the detection of an impurity – N-Nitroso-N You can also reach the Horizon NJ Health Pharmacy Help Desk at 1-800-682-9094 x81016
5 mg: BLL801A: Dec-19: 33342-051-10: Macleods Pharmaceuticals Limited: Losartan Potassium and Hydrochlorothiazide Tablets 100 mg/ 12
To date, Sandoz Inc
Camber, Avet, Teva, and Torrent were affected by the recall
— Torrent initially announced a consumer-level recall of losartan on December 20, 2018
— Refer to the FDA site for updates regarding angiotensin II receptor blocker recalls
In December 2018, January 2019, Torrent recalled 10 lots of losartan potassium 100 mg tablets
• For more information regarding this recall, contact Torrent at 1-800-912-9561 or Qualanex at 1-888-280-2020 for general questions regarding return of the product